Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Drug response of head and neck tumors in native-state histoculture.
Robbins KT, Varki NM, Storniolo AM, Hoffman H, Hoffman RM. Robbins KT, et al. Among authors: storniolo am. Arch Otolaryngol Head Neck Surg. 1991 Jan;117(1):83-6. doi: 10.1001/archotol.1991.01870130089022. Arch Otolaryngol Head Neck Surg. 1991. PMID: 1986767
Surgery vs chemotherapy.
Robbins KT, Storniolo AM. Robbins KT, et al. Among authors: storniolo am. Arch Otolaryngol Head Neck Surg. 1992 Dec;118(12):1365-6. doi: 10.1001/archotol.1992.01880120091017. Arch Otolaryngol Head Neck Surg. 1992. PMID: 1449701 No abstract available.
Sequential cycles of high-dose carboplatin administered with recombinant human granulocyte-macrophage colony-stimulating factor and repeated infusions of autologous peripheral-blood progenitor cells: a novel and effective method for delivering multiple courses of dose-intensive therapy.
Shea TC, Mason JR, Storniolo AM, Newton B, Breslin M, Mullen M, Ward DM, Miller L, Christian M, Taetle R. Shea TC, et al. Among authors: storniolo am. J Clin Oncol. 1992 Mar;10(3):464-73. doi: 10.1200/JCO.1992.10.3.464. J Clin Oncol. 1992. PMID: 1740685
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD, Von Hoff DD. Burris HA 3rd, et al. Among authors: storniolo am. J Clin Oncol. 1997 Jun;15(6):2403-13. doi: 10.1200/JCO.1997.15.6.2403. J Clin Oncol. 1997. PMID: 9196156 Clinical Trial.
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer.
Rothenberg ML, Moore MJ, Cripps MC, Andersen JS, Portenoy RK, Burris HA 3rd, Green MR, Tarassoff PG, Brown TD, Casper ES, Storniolo AM, Von Hoff DD. Rothenberg ML, et al. Among authors: storniolo am. Ann Oncol. 1996 Apr;7(4):347-53. doi: 10.1093/oxfordjournals.annonc.a010600. Ann Oncol. 1996. PMID: 8805925 Free article. Clinical Trial.
154 results